Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.43 |
| ▸ | FEN1 | P39748 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3742612 | 0.80 | TDP1 (0.52) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| Methylamine SCHEMBL13837152 | 0.77 | MAPT (0.48) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL7440716 | 0.74 | TDP1 (0.50) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL19619388 | 0.72 | MAPT (0.52) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL3754394 | 0.72 | MAPT (0.52) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL28352832 | 0.72 | CES1 (0.52) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL70367 | 0.71 | CES1 (0.56) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| Hydrochloric Acid SCHEMBL10431496 | 0.71 | MAPT (0.50) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL10393811 | 0.70 | KMT2A (0.45) | MAPK1MEN1CYP3A4HPGDKMT2A | |
| SCHEMBL379725 | 0.70 | KMT2A (0.54) | MAPK1MEN1CYP3A4HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106573959-B | Modified cyclic pentapeptides and uses thereof | 慕尼黑工业大学 | 2022-03-25 | — | — | CN | disclosed |
| US-10919938-B2 | Modified cyclopentapeptides and uses thereof | Technische Universität München (DE) | 2021-02-16 | — | — | US | disclosed |
| EP-3152226-B1 | MODIFIED CYCLOPENTAPEPTIDES AND USES THEREOF | UNIV MUENCHEN TECH (DE) | 2019-05-29 | — | — | EP | disclosed |
| US-20180037608-A1 | MODIFIED CYCLOPENTAPEPTIDES AND USES THEREOF | Technische Universität München (DE) | 2018-02-08 | — | — | US | disclosed |
| EP-3152226-A1 | MODIFIED CYCLOPENTAPEPTIDES AND USES THEREOF | Technische Universität München (DE) | 2017-04-12 | — | — | EP | disclosed |
| EP-2560690-B1 | CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF | Technische Universität München (DE) | 2017-03-08 | — | — | EP | disclosed |
| US-9266924-B2 | Cyclopentapeptide derivatives and uses thereof | Technische Universität München (DE) | 2016-02-23 | — | — | US | disclosed |
| WO-2015185162-A1 | MODIFIED CYCLOPENTAPEPTIDES AND USES THEREOF | Technische Universität München (DE) | 2015-12-10 | — | — | WO | disclosed |
| US-20130217871-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-08-22 | — | — | US | disclosed |
| US-20130129622-A1 | CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF | Technische Universität München (DE) | 2013-05-23 | — | — | US | disclosed |
| EP-2590678-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | Fresenius Kabi Deutschland GmbH (DE) | 2013-05-15 | — | — | EP | disclosed |
| EP-2560690-A1 | CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF | Technische Universität München (DE) | 2013-02-27 | — | — | EP | disclosed |
| WO-2012004009-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2012-01-12 | — | — | WO | disclosed |
| WO-2011131731-A1 | CYCLOPEPTIDE DERIVATIVES AND USES THEREOF | Technische Universität München (DE) | 2011-10-27 | — | — | WO | disclosed |
| WO-2011131735-A1 | CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF | Technische Universität München (DE) | 2011-10-27 | — | — | WO | disclosed |
| EP-2380596-A1 | Cyclopentapeptide derivatives and uses thereof | Technische Universität München (DE) | 2011-10-26 | — | — | EP | disclosed |
| EP-2380597-A1 | Cyclopeptide derivatives and uses thereof | Technische Universität München (DE) | 2011-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037608-A1 | MODIFIED CYCLOPENTAPEPTIDES AND USES THEREOF | ANXA4, CPA4, PTMS | MAPK1 1459/4885MEN1 3261/4885CYP3A4 909/4885 |
| US-20130129622-A1 | CYCLOPENTAPEPTIDE DERIVATIVES AND USES THEREOF | ANXA4, XPNPEP1, ANXA1 | MAPK1 1774/4885MEN1 1927/4885CYP3A4 427/4885 |
| US-10919938-B2 | Modified cyclopentapeptides and uses thereof | ANXA4, CPA4, PTMS | MAPK1 1459/4885MEN1 3261/4885CYP3A4 909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.